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ABSTRACT
Purpose: W e evaluated the impact of lower energy transurethral microwave thermotherapy 
on quality of life and quality of sexual function in patients w ith benign prostatic hyperplasia
(B PH ).
M aterials and Methods: A  total of 50 patients with BPH  were randomized to receive either 
lower energy transurethral microwave thermotherapy treatment (Prostasoft 2.0)* or placebo 
treatment and followed for 26 weeks after treatment. A ll patients completed a Madsen symptom 
score and quality of life questionnaire to assess acceptability, daily activities, psychological 
well-being, social activities and improvement in quality of life. A sexual function questionnaire 
was used to assess changes in sexual function after microwave thermotherapy.
Results: A  significant difference in voiding parameters and symptom score was found between 
the transurethral microwave thermotherapy and sham groups. Maximum uroflow changed from 
9.6 ml. per second at baseline to 13.9 ml. per second and from 9.9 ml. per second at baseline 
to 9.6 ml. per second at 26 weeks for transurethral microwave thermotherapy and sham groups, 
respectively. Madsen score improved from 13.2 to 5.3 for the transurethral microwave thermo­
therapy group and from 11.9 to 9.1 for the sham group. For quality of life measures, a statistically 
significant difference in favor of the transurethral microwave thermotherapy group was found 
only for the acceptability item. A t baseline and after 26 weeks no statistically significant 
difference was observed between the 2 groups for Quality of Life measures documenting sexual 
function. However, almost 20% of patients treated by either transurethral microwave thermo­
therapy or sham claimed at 26 weeks after treatment that treatment had influenced sexual 
function.
Conclusions: Although significant changes in objective and subjective parameters were found 
in patients after lower energy microwave thermotherapy, the change in quality of life was 
minimal. In  addition to the minimal invasiveness of transurethral microwave thermotherapy, 
preservation of sexual function is appealing.
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Although benign prostatic hyperplasia (BPH) can lead to 
serious complications in some patients1 the majority of pa­
tients seeldng medical attention do so because of bothersome 
symptoms that affect the quality of their lives. The decision 
to treat a patient is based largely on the extent to which 
symptoms interfere with daily activities.2 Individual patient 
views of bother will vary significantly, and so the degree of 
symptom severity is important in overall patient outlook. 
Consequently selection of treatment is based primarily on 
individual view of benefit (symptoms improvement) versus 
risk.
Transurethral prostatectomy has become well established 
as standard surgical technique for BPH  unless the prostate 
gland is too large.3’4 This standard has been challenged in 
recent years by several alternative treatments for BPH. Be­
sides being less invasive with decreased need for anesthesia, 
a considerably lower morbidity and mortality rate is claimed 
for alternative treatments. Transurethral microwave ther­
motherapy has engendered great enthusiasm as alternative 
minimally invasive treatment for patients with BPH. Trans­
urethral microwave thermo therapy uses a combination of
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transurethrally administered radiating heat energy and con­
ductive cooling administered via the urethra. Treatment re­
sults in high power microwave application deep in the lateral 
lobes, leading to irreversible cell damage of prostatic tissue 
without damaging the urethra. The effectiveness of treat­
ment has not surpassed that of transurethral prostate resec­
tion ,5
Before treatment patients appear to have different symp­
tom severity and health status.6 Moreover, we suggest that 
alternative treatments have a different impact on changes in 
quality of life than transurethral prostatectomy in patients 
with BPH. This explains why the development of a BPH 
specific health related quality of life outcome measure is an 
essential requirement to allow time related comparison 
among treatments for BPH.7 Demand for minimally invasive 
medical care by increasing numbers of younger, less symp­
tomatic and sexually active male patients needs our atten­
tion. Nothing is known about the effect on quality of life after 
thermo therapy. In our study changes in quality of life and in 
sexual function were evaluated in patients participating in a 
placebo controlled transurethral microwave thermotherapy 
study.
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MATERIALS AND METHODS
From June 1991 through December 1992, 50 men 50 to 79 
years old with symptoms of BPH were randomized to receive 
transurethral microwave thermotherapy or sham treatment. 
Patients were included according to age 45 years old or older, 
duration of symptoms 3 months or longer, Madsen symptom 
score 8 points or higher, prostate volume 30 cm.0 or greater 
and peak uroflow less than 15 ml. per second. Major exclu­
sion criteria were prostatic carcinoma, neurogenic bladder 
dysfunction, history of prostate surgery and isolated enlarge­
ment of middle lobe. For this study we used the lower energy 
thermotherapy protocol (Prostasoft 2.0).*
Screening included general history, complete physical ex­
amination, blood biochemistry (including prostate specific 
antigen) and urine examination (including cytology). Sever­
ity of symptoms was rated according to Madsen symptom 
score.8 All patients were asked to complete a quality of life 
and sexual function questionnaire.
Patients were randomized after informed consent was ob­
tained. Procedure for transurethral microwave thermother- 
apy has been described elsewhere.9*10 If the patient was 
randomized to receive sham treatment, the same procedure 
was performed but no microwave energy was applied. A 
customized sham program was run on the computer to give a 
simulated treatment display on the visual display unit. Pa­
tients were evaluated at 12 and 26 weeks after treatment. If 
a sham treated patient did not experience improvement at 3 
months, a second real transurethral microwave thermother­
apy was administered if requested.
The questionnaire was designed specifically to assess qual­
ity of life in patients with BPH under treatment and it 
covers several dimensions (see Appendix). The 36-item- 
questionnaire assesses acceptability (12 items), daily activi­
ties (6), psychological well-being (8), social activities (6) and 
overall improvement. Our questionnaire is composed of qual­
ity of life questionnaire currently in evaluation in other 
studies.
The questionnaire was designed to assess changes in sex­
ual function after thermo therapy and it encompasses the 
following items: 1) do you have a partner (yes/no), 2) do you 
have sexual intercourse (yes/no), 3) the quality of sexual
intercourse (good/bad), 4) do you have an orgasm (yes/no), 5) 
do you have an ejaculation (yes/no) and 6) do you experience
pain during intercourse (yes/no).
Cronbach’s a  was used to measure internal consistency of 
the Madsen symptom score items and overall score of ques­
tions related to quality of life. Correlations between total 
scores were calculated using the Spearman rank correlation 
test. The Student t test was used at each point of meas­
urement to test statistically significant differences between 
the 2 groups in changes after treatment (clinical parameters, 
quality of life and Madsen symptom score variables). Single 
item differences between groups were tested for statistical 
significance using the chi-square test and 2-sided Fisher’s 
exact test for 2 X 2 tables.
RESULTS
Mean patient age was 63.3 years (range 50.4 to 78.4). Of 50 
patients randomized 47 could be included for evaluation. One 
patient refused treatment and 2 had incomplete data. At 
baseline there were no statistically significant differences 
between either group for all parameter (see table). A previous 
analysis showed significant difference in efficacy parameters 
between the 2 groups in favor of transurethral microwave 
thermotherapy,11
In our study patients were excluded for evaluation if they 
opted for transurethral microwave thermo therapy treatment 
at 3 months of foliowup (failure of treatment, 15 cases) or 
refused further folio wup for personal reasons. Exclusion rate 
for the entire group was 17 and 20 at 12 and 26 weeks, 
respectively, resulting in a complete data set in 47, 47 and 30 
patients at baseline, 12 and 26 weeks followup, respectively. 
Exclusion rate at 26 weeks was significantly higher in the 
sham group (13) compared to the transurethral microwave 
thermotherapy group (7) (chi square test, p = 0.03).
Q uality of life. The Madsen symptom score was completed 
by all participants at every point of measurement. Also, 
quality of life questions were completed adequately except for
3 questions concerning social activities. On average 98, 96 
and 93% of the questions were completed at baseline, 12 
weeks and 26 weeks, respectively. It appeared that in a small
Difference in clinical outcome parameters and quality of life following transurethral microwave thermotherapy and sham at 12 and 26
weeks using the condition of last observation carried, forward
No. Mean at Baseline (SD) No. Mean at Week 12 (SD) No. Moan at Week 26 (SD) p Value:i:
Maximum flow rate:
Thermotherapy 24 9.6 (0.5) 24 13.0 (1.0) 24 13.9 (1.3) 0.002t
Sham 23 9.9 (0.6) 23 9.6 (0.7) 22 9.6 (0.6)
Voided vol.:
Thermotherapy 24 267.0 (24.8) 24 267.8 (22.7) 24 298.6 (20.5) 0.116
Sham 23 259.9 (26.7) 23 243.7 (21.2) 22 232.2 (21.3)
Post-voided vol.:
Thermotherapy 24 46.1 (8.1) 24 26.3 (9.1) 24 30.7 (9.0) 0.428
Sham 23 60.8(11.6) 23 59.0 (12.2) 22 56.1(12.8)
Madsen:
Thermotherapy 24 13.2 (0.7) 24 5.9 (0.8) 24 5.3 (0.9) o.ooitSham 23 11.9 (0.6) 23 7.9 (0.9) 23 9.1 (0.9)
Acceptance!
Thermotherapy 24 11.8 (0.7) 23 8.8 (0.8) 19 7.4 (0.4) 0.007t
Sham 22 10.3 (0.7) 21 8.0 (0.5) 17 8.1 (0.5)
Daily activities^
Thermotherapy 24 14.3 (0.8) 23 12.1 (0.8) 21 11.0 (0.5) 0.168
Sham 22 12,5 (0.4) 21 10.6 (0.3) 19 10.7 (0.4)
Psychological well-being!
Thermotherapy 24 27.7 (0.8) 23 29.3 (0.8) 21 29.9 (0.7) 0.320
Sham 22 29.4 (0.8) 21 30.9 (0.6) 19 30.6 (0.7)
Social activities!
Thermotherapy 21 10.2 (1.2) 21 10.9 (1.4) 19 9.9 (1.4) 0.759Sham 19 14.6 (3.5) 18 17.5 (3.4) 16 11.8 Í3.0)
Improvements!
Thermotherapy
Sham
J  » i
Not applicable 
Not applicable
C M .____ 1 ____J - Î  _  i t _____ i
23
21
10.0 (0.5)
11.0 (0.4)
21
19
10.5 (0.4)
11.5 (0.3)
0.580
* Statistically significant according to Student’s t test.
t  Difference in changes since baseline between transurethral microwave thermotherapy and sham at week 26. 
$ Subgroup of quality of life questions.
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number of cases (up to 5%) 1 item was missing from a total 
score at a certain point of measurement. Missing items were 
considered to be random and, consequently, they were com- 
pleted with the mean of the known items when we con­
structed the overall scores. The standardized Cronbach a of 
all quality of life questionnaire scores ranged from 0.74 to
0.88 and was not improved if items were deleted, indicating 
internal consistency of scores was good.
There appeared to be a considerable number of dropouts. 
To overcome this problem an analysis was carried out accord­
ing to last observation carried forward. Missing data at fol­
io wup were replaced by last known value during followup. 
We observed improvement after screening. This method pre­
sumes that patients who are lost to followup do not worsen 
when compared to the last followup, and so this method may 
underestimate possible further improvement.
Results of the total score of quality of life measures eval­
uated at baseline, 12 weeks and 26 weeks are presented in 
the table. No statistically significant differences were found 
at baseline for all parameters. At 12-week followup there was 
a statistically significant difference in improvement of max­
imum uroflow and Madsen symptom score between both 
groups. No statistically significant difference was observed 
for any overall scores of quality of life measures. At 26 weeks 
we observed sustained improvement in the aforementioned 
parameters and a statistically significant difference in qual­
ity of life concerning acceptance of voiding problems by the 
transurethral microwave thermotherapy group.
Sexual function. At baseline 40 patients (86%) had a steady 
partner, 91% were still sexually active and 60% graded their 
sexual activity as satisfying. An orgasm could be reached by 
92%, 97% had antegrade ejaculation and 14% experienced 
pain during intercourse. At baseline and after 26 weeks no 
statistically significant difference was observed between the 
two groups for quality of life measures documenting sexual 
function. No significant differences were found in sexual func­
tion changes between the 2 treatment options. However, almost 
20% of patients treated by either transurethral microwave ther­
motherapy or sham claimed at 26 weeks after treatment that 
treatment had influenced sexual function. Change in sexual 
function was not reflected in responses documented in the post­
therapy questionnaire, with 21% of patients grading sexual 
function as satisfying and 26% as dissatisfying. Sexual activi­
ties at 26-week followup were more or less unchanged when 
compared to baseline. Overall 86% of patients reported having 
orgasms and 89% documented having an antegrade ejaculation. 
No changes were found with respect to discomfort during inter­
course.
DISCUSSION
Treatment of BPH  has been redefined during the last de­
cade because of extensive investigation of alternative treat­
ments. Several factors have modified general treatment pat­
terns, including recognition of risk and limitations of 
prostatectomy, acceptance of medical therapies, development 
of minimally invasive treatment alternatives and progress in 
understanding appropriate indications for intervention. 
Since BPH  is rarely a life threatening condition, therapy 
aims to improve quality of life by relieving bothersome uri­
nary symptoms.
In our study at every point of followup we found significant 
differences in improvement of voiding parameters and symp­
tom scores in favor of the transurethral microwave thermo­
therapy group. Improvement was not reflected in changes in 
quality of life measures. At 12-week followup no differences 
were found for any of the parameters while at 26 weeks only 
a significant difference was found for acceptance of voiding 
problems.
One explanation for these findings is that maybe the qual­
ity of life questionnaire is not disease specific. When this
study was conducted (1991 to 1992) no validated quality of 
life questionnaires were available for BPH. Consequently the 
questionnaire used was extrapolated from other question­
naires available at that time. Currently we lack a validated 
quality of life questionnaire. Several groups are evaluating 
and validating quality of life questionnaires.12 Another rea­
son for the poor quality of life results could be discrepancy 
between statistical significance and clinical significance. Al­
though in our study a statistically significant difference in 
improvement of objective and subjective parameters was 
seen between the 2 groups, the clinical difference may be less 
significant. However, improvement in uroflow was higher in 
the transurethral microwave thermotherapy group and ab­
solute improvement was on average in the range of 3 to 4 ml. 
per second. Also, the decrease in symptom score was signif­
icantly better for the transurethral microwave thermother­
apy group when compared to the sham group. Therefore, this 
argument is not valid to explain the difference.
Severity of symptoms alone does not predict health care 
seeking behavior14 while increased bother is predictive of 
health care seeking behavior.13 Because worry and embar­
rassment about urinary functions are relevant quality of life 
issues, together with urinary symptoms and psychological 
state, it is obvious that these may be important determinants 
in health care seeking behavior among men with BPH. 
Maybe symptom scores and quality of life questionnaires 
measure completely different aspects of the disease, thus 
explaining the discrepancy between changes in symptoms 
and quality of life. In other words, if a patient experiences an 
increase in flow rate with persisting nocturia, this will lead to 
a decrease in symptoms but the nocturia may still bother him 
significantly, resulting in no changes in quality of life, In 
another case one may find that no significant changes in the 
majority of symptoms occurs but a minimal decrease in fre­
quency of voiding may already result in significant improve­
ment in quality of life. Data to support this finding are 
limited. Until now only a few studies presented results of 
studies that included quality of life questionnaires. The way 
in which quality of life is adversely affected by BPH has also 
been studied by Tsang and Garraway.1^ These authors dem­
onstrated that symptoms of BPH are associated with restric­
tions in activities of daily living, including sleeping, driving, 
playing outdoor sports, and visiting the cinema and theatre.
However, impairment of quality of life by BPH alone is not 
enough to induce many affected individuals to seek health 
care. The 2 other factors that may also be important are 
worry and embarrassment about urinary tract functions. 
These factors were not included in questionnaires in our 
study and, therefore, cannot be addressed. Because the ques­
tionnaire is used to document changes, application of higher 
energy thermotherapy levels may result in better objective 
and/or subjective outcome and more significant improvement 
in quality of life.15
An increasing number of younger, less symptomatic and 
sexually active patients seek medical help because of voiding 
dysfunction. Few scales currently used in BPH research take 
sexuality into account, probably because BPH in itself does 
not affect sexuality of patients. However, the International 
Continence Society BPH study showed that sexual activities 
of patients frequently were spoiled by voiding problems.12 
Nevertheless sexuality is indeed an essential component of 
quality of life in male patients. Given the fact that the ma­
jority of patients seeking medical treatment are sexually 
active, the impact of BPH treatments on sexuality should be 
integrated into all disease specific outcome measures.
What is the effect of surgical therapy on sexual function? 
According to Montgomery et al a considerable number of 
urologists are not documenting well enough their counseling 
of men undergoing prostatectomy.16 We agree that sexually 
active men should be counseled about risk of ejaculatory 
disruption and that such counsel should be documented in
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patient notes. It would seem wise to warn sexually active 
men that there may be a slight risk of erectile dysfunction.
Data on the effect of transurethral microwave thermother­
apy on sexual function are minimal.10 In our study no major 
changes in sexual function were observed. Although a signif­
icant number of patients mentioned changes in sexual func­
tion, no significant difference was found between either 
group. Therefore, we conclude that lower energy thermother­
apy (software version 2.0) does not significantly change sex­
ual function. Obviously this statement does not hold for the 
individual patient.
CONCLUSIONS
Significant changes in objective and subjective parameters 
are found in patients after lower energy transurethral micro­
wave thermotherapy. Pio we ver, changes in quality of life 
measures are minimal and limited to improvement in accept­
ability measures only. The minimal invasiveness of this ther­
apy, especially preservation of sexual function, is appealing.
APPENDIX
This is a translation of the Quality of Life questionnaire 
used for our study. This is not a validated questionnaire. We 
evaluated the overall score of different subgroups to study 
differences between the 2 groups. All answers were adjusted 
in the evaluation so that the lower the score, the less severe 
the complaint. Questions for which the patient could fill in a 
number were omitted from the evaluation.
A. YOUR ACCEPTANCE OF THE URINATING PROB­
LEM DURING THE LAST MONTH
1. How many problems did you have with the urinating 
habit?
1. none
2. few
3. considerable
4. many
2. How much did the voiding problem affect your normal 
physical activities?
1. not
2. little
3. considerably
4. enormously
3. How much did the voiding problem affect your normal 
social life?
1. not
2. little
3. considerably
4. enormously
4. Did you have to urinate without being able to control the 
moment of urinating?
1. never
2. yes, 1 or 2 times this month
3. yes, 1 or 2 times every week
4. yes, every day
5. Did you wet your clothes (as a result of not being able to 
hold the urine?)
1. never
2. yes, 1 or 2 times this month
3. yes, 1 or 2 times every week
4. yes, every day
6. Did you ever wet your bed?
1. never
2. yes, 1 or 2 times this month
3. yes, 1 or 2 times every week
4. yes, every day
7. Did you ever use a penile clamp or condom to prevent 
wetting your clothes?
1. never
2. yes, 1 or 2 times this month
3. yes, 1 or 2 times every week
4. yes, every day
. Did the use of a penile clamp or condom to prevent 
wetting your clothes affect your normal physical activ­
ities?
1. never
2. unaffected
3. hardly affected
4. considerably affected
5. much affected
9. Did the use of a penile clamp or a condom to prevent 
wetting your clothes affect your normal social life?
1. never
2. unaffected
3. hardly affected
4. considerably affected
5. much affected
10a. To indicate how unpleasant the problems were during 
the last month, tick the appropriate answer.
a) dripping or wetting clothes?
1. no problem
2. very small problem
3. small problem
4. a problem
5. a big problem
b) the unpleasant feeling of a full bladder?
1. no problem
2. very small problem
3. small problem
4. a problem
5. a big problem
c) afraid that you cannot urinate at all at a certain mo­
ment when having a full bladder?
1. no problem
2. very small problem
3. small problem
4. a problem
5. a big problem
d) worried about the long distance you still have to go 
before being able to urinate?
1. no problem
2. very small problem
3. small problem
4. a problem
5. a big problem
e) being embarrassed because you have to go to the bath­
room too often?
1. no problem
2. very small problem
3. small problem
4. a problem
5. a big problem
B. DAILY ACTIVITIES OF THE LAST MONTH
1. How often have you been worried about your voiding 
complaints?
1. never
2. sometimes
3. often
4. most of the time
2. How often did your voiding problem hinder your normal 
daily activities?
1. never
2. sometimes
3. regularly
4. the greater part of the day
5. always
3. How often was it due to your voiding problem that your
QUALITY OF LIFE ASSESSMENT IN PATIENTS TREATED WITH LOWER ENERGY THERMOTHERAPY 1843
normal load of work, home tasks or hobbies were being 
limited?
1. never
2. sometimes
3. regularly
4. the greater part of the day
5. always
4. Did you have a problem with your normal daily physical 
activities such as climbing stairs, climbing hills, long 
standing or sitting, carrying a heavy load?
1. no, never
2. sometimes
3. regularly
4. often
5. always
5 . Did your voiding problem influence your regular rest or 
sleep habits?
1. no, never
2. a little
3. regularly
4. a lot
6. How many days during the last month did you have to 
stay in bed because of your voiding problem?
7. Did your voiding problem inhibit you from driving a car?
1. I don’t drive
2. never
3. sometimes
4. regularly
5. a lot
8. Did your voiding problem inhibit you from participating 
in light physical activities like swimming or bowling?
1. never
2. sometimes
3. regularly
4. a lot
9. Did your voiding problem inhibit you from participating 
in physical activities like jogging?
1. never
2. sometimes
3. regularly
4. a lot
C. GENERAL PSYCHOLOGICAL W ELL-BEING
1. How would you like to describe your physical condition 
generally?
1. very well
2. good
3. average
4. bad
2. How energetic or vital do you feel normally?
1. always very energetic
2. most of the time energetic
3. most of the time little energy
4. very little energy
5. no energy, listless
3. To what extent did nervous complaints or nervousness 
bother you during the last month?
1. much
2. considerably
3. somewhat, enough to be worried
4. a little bit
5. never
4. Did you have depressive feelings during the last month?
1. yes, every day sometimes
2. yes, almost every day depressive feelings
3. yes, several days I felt depressed
4. sometimes some depressive feelings
5. no, I didn’t feel depressed
5. Were you afraid, worried or confused during the last 
month?
1. a lot
2. considerably
3. somewhat, enough to be worried
4. a little bit
5. never
6. Did you feel down during the last month?
1. always
2. mostly
3. the greater part of the time
4. a considerable part of the time
5. sometimes
6. never
7. How would you like to describe your psychological (men­
tal) condition?
1. very well
2. good
3. average
4. bad
8. Did your general psychological condition during the last 
2 to 3 months:
1. worsen enormously
2. worsen a little bit
3. stay the same
4. somewhat improved
5. enormously improved
D. SOCIAL ACTIVITIES
1. How many familiar persons in your neighborhood do 
you see regularly?
2. How many close friends do you have?
3. How often do you go out with friends or relatives or do 
you visit each other?
1. every day
2. several days a week
3. once a week
4. 2 or 3 times monthly
5. once monthly
6. 5 to 10 times yearly
7. less than 5 times yearly
4. How often did you receive friends at home during the 
last month?
1. every day
2. several days a week
3. once a week
4. 2 or 3 times monthly
5. once monthly
6. no visit during the last month
5. How often did you visit a friend during the last month?
1. every day
2. several days a week
3. once a week
4. 2 or 3 times monthly
5. once monthly
6. no visit during the last month
6. During the last 2 to 3 months did your general social 
well-being
1. worsen enormously
2. worsen a little bit
3. stay the same
4. improve somewhat
5. improve enormously
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ED ITO R IA L COM M ENT
It is satisfying to see a randomized study that evaluates emerging 
technologies for treatment of BPH. In this case the investigators 
examined the effect of microwave treatment on urinary symptoms 
and selected quality of life measures. Notably, they demonstrated 
statistically significant minor improvements in flow rate and accep­
tance, and moderate improvement in urinary symptoms at 26 weeks. 
They also demonstrated that treatment of urinary symptoms was not 
associated with general quality of life, which is consistent with 
previous work on the (non)interaction of urinary symptoms and 
general quality of life (reference 2 in article).1 The noninteraction of 
urinary symptoms and general quality of life means that these 
dimensions of health are distinct and suggests that they are mini­
mally causally linked.
As we compare technologies, 2 methodological issues will become 
pivotal. First, the proportion lost to followup should be minimized, as 
even the creative imputations used here are no substitute for real 
data. Second, to draw valid comparisons studies will have to rely on 
identical or equivalent instruments.2 Preferably, studies will use 
instruments whose scoring and general characteristics have been 
described and accepted, which will engender more confidence in the 
inferred therapeutic effects.
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